Publications – CAUSALab

Chronic prescription opioid use in pregnancy in the United States.

Author(s): Straub L, Huybrechts KF, Hernández-Díaz S, Zhu Y, Vine S, Desai RJ, Gray KJ, Bateman BTJournal: Pharmacoepidemiol Drug SafPMID: 33428239 August 2021

To evaluate chronic opioid utilization patterns during pregnancy using nationwide data from publicly and commercially insured women.

Safety of Tenofovir Disoproxil Fumarate (TDF) for Pregnant Women facing the COVID-19 Pandemic.

Author(s): Hernández-Díaz S, Bateman BT, Straub L, Zhu Y, Mogun H, Fischer M, Huybrechts KFJournal: Am J EpidemiolPMID: 33847737 August 2021

We assessed the teratogenicity of tenofovir, a human immunodeficiency virus (HIV) drug similar to remdesivir currently being evaluated for the…

Active Surveillance of the Safety of Medications Used During Pregnancy.

Author(s): Huybrechts KF, Kulldorff M, Hernández-Díaz S, Bateman BT, Zhu Y, Mogun H, Wang SVJournal: Am J EpidemiolPMID: 33423046 August 2021

The scientific community relies on postmarketing approaches to define the risk of using medications in pregnancy because information available at…

Validation of a claims-based algorithm to identify pregestational diabetes among pregnant women in the United States.

Author(s): Wood ME, Chen ST, Huybrechts KF, Bateman BT, Gray KJ, Seely EW, Zhu Y, Mogun H, Patorno E, Hernández-Díaz SJournal: EpidemiologyPMID: 34183529 August 2021

Identifying pregestational diabetes in pregnant women using administrative claims databases is important for studies of the safety of antidiabetic treatment…